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Abstract
Introduction While early psychosis intervention
(EPI) has proliferated in recent years amid evidence
of its effectiveness, programmes often struggle to
deliver consistent, recovery-based care. NAVIGATE is a
manualised model of EPI with demonstrated effectiveness
consisting of four components: individualised medication
management, individual resiliency training, supported
employment and education and family education.
We aim to implement NAVIGATE in geographically
diverse EPI programmes in Ontario, Canada, evaluating
implementation and its effect on fidelity to the EPI model,
as well as individual-level outcomes (patient/family
member-reported and interviewer-rated), system-level
outcomes (captured in provincial administrative databases)
and engagement of participants with lived experience.
Methods and analysis This is a multisite, non-
randomised pragmatic hybrid effectiveness-
implementation type III mixed methods study coordinated
at the Centre for Addiction and Mental Health (CAMH) in
Toronto. Implementation is supported by the Provincial
System Support Program, a CAMH-based programme
with provincial offices across Ontario, and Extension of
Community Healthcare Outcomes Ontario Mental Health at
CAMH and the University of Toronto. The primary outcome
is fidelity to the EPI model as measured using the First
Episode Psychosis Services—Fidelity Scale. Four hundred
participants in the EPI programmes will be recruited and
followed using both individual-level assessments and
health administrative data for 2 years following NAVIGATE
initiation. People with lived experience will be engaged
in all aspects of the project, including through youth and
family advisory committees.

Strengths and limitations of this study
►► Real-world design leveraging routinely collected ad-

ministrative data, established network of early psychosis intervention programmes and routine fidelity
assessments.
►► Implementation supported by regional specialists
and Project Extension of Community Healthcare
Outcomes, a digitally supported hub-
and-
spoke
training model.
►► Collaboration with youth, family members and other
stakeholders including government policymakers at
all stages of the project.
►► Interpretation of findings limited by absence of a
comparison group for individual-level (patient/family
member-reported and interviewer-rated) outcomes.

Ethics and dissemination Research ethics board
approval has been obtained from CAMH and institutions
overseeing the local EPI programmes. Study findings
will be reported in scientific journal articles and shared
with key stakeholders including youth, family members,
programme staff and policymakers.
Trial registration number NCT03919760; Pre-results.

Introduction
Psychosis typically has its onset in youth and
emerging adults (YEAs), a critical developmental stage for exploring and solidifying future career trajectories, intimate
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relationships and worldviews.1–3 Psychosis is a group of
symptoms characteristic of diagnoses of schizophrenia,
schizoaffective disorder, substance-
induced psychotic
disorders and bipolar disorder or major depressive
disorder with psychotic features; taken together, these
disorders account for the greatest disability among
all medical illnesses in YEAs in developed countries.4
Furthermore, these conditions account for high healthcare costs.5 They can have a profound effect on young
people: evidence suggests that a recent diagnosis of
psychotic disorder confers an 8–24-fold greater mortality
rate among YEAs compared with the general population, mostly due to suicide.6 7 Even after accounting for
suicide, people with these disorders experience a shortened lifespan attributable to downward socioeconomic
drift and poorly treated comorbid physical health disorders.8–10 Consistent evidence has demonstrated that
longer duration of untreated psychosis is associated with
more severe symptoms, lower likelihood of remission,
poor social functioning and global outcome.11
Early psychosis intervention (EPI) programmes are
designed to reduce barriers to treatment and improve
recovery from first-episode psychosis (FEP). In a naturalistic study in Ontario, receiving care in an EPI programme
was associated with improved access to psychiatric care,
fewer emergency department (ED) visits and reduced all-
cause mortality.12 Additional benefits associated with EPI
in the literature include improved psychosis symptoms
and reduced risk of relapse, fewer hospital readmissions
and increased employment rates.13–16 Evidence suggests
that EPI is likely cost effective, and possibly even cost
saving compared with alternatives.17 Despite the demonstrated benefits of EPI, disability associated with psychotic
disorders has not improved,18 and recovery rates in EPI
programmes remain low.19 Achieving consistent delivery
of high-quality, evidence-based care in EPI programmes
is a major challenge.20 This may be related to specific
deficits in delivering recovery-based services, including
case management coupled with individualised psychosocial interventions, family education and support, and
supported education and employment. Even in clinical
service delivery trials, only a minority of patients receive
the full range of psychosocial interventions offered by the
service.13 14 Effective implementation and sustainability of
recovery-based care in real-world EPI settings remains a
challenge.21–24
The province of Ontario, Canada has prioritised EPI
care through a separate funding stream and the establishment of EPI programme standards,25 with over 50
EPI sites delivering care for both non-affective and affective psychosis (ie, bipolar disorder and major depressive
disorder with psychotic features). These EPI programmes
are coordinated through the Early Psychosis Intervention
Ontario Network (EPION), which receives funding from
the Ministry of Health and operational, professional and
financial management support from the Provincial System
Support Program (PSSP), based at the Centre for Addiction and Mental Health (CAMH) in Toronto. EPION and
2

PSSP led a pilot study to measure fidelity to current EPI
standards using the First Episode Psychosis Services—
Fidelity Scale (FEPS-FS)26 completed by peer assessors.27
The study found that the assessed EPI programmes
lacked a structured or manualised process for delivering
recovery-oriented care, which aligned with a prior key
informant survey in which Ontario EPI programmes cited
a need for tools to support service delivery, access to staff
training and guidance on implementing new practices.22
Despite being connected by EPION, these programmes
felt they were lacking a community of practice.
NAVIGATE was developed and studied with funding
from the National Institute of Mental Health Recovery
After an Initial Schizophrenia Episode (RAISE) Initiative.
A model that addresses the need for consistently delivered recovery-
based services, NAVIGATE is a form of
coordinated specialty care for FEP consisting of four key
intervention components: (1) individualised medication
management using a decision support tool, (2) a package
of psychoeducation and a blend of evidence-
based
psychotherapies called ‘individual resiliency training’, (3)
supported employment and education and (4) a family
education programme.28 NAVIGATE operationalises
current EPI standards using manualised protocols, and
systematically applies the four components to all patients.
Regular team reviews assess patient progress, fidelity and
need for adjustments. NAVIGATE was evaluated from
2009 to 2014 in a cluster randomised controlled trial
(RCT) involving 404 individuals with FEP in 34 community mental health centres across the USA with no pre-
existing EPI programmes.21 Compared with usual care,
NAVIGATE treatment provided greater improvement in
symptoms and real-world functioning, including social
functioning and engagement in educational and vocational training.21 29
CAMH, having implemented NAVIGATE in its EPI
programme, partnered with PSSP, EPION, the Ontario
Ministry of Health and former EPI service users on a Canadian Institutes of Health Research Strategy for Patient-
Oriented Research Innovative Clinical Trials grant to
evaluate implementation of NAVIGATE in diverse EPI
sites across the province. Implementation support is
provided by PSSP. Training is delivered by experts who
developed the NAVIGATE model, as well as expert users
from CAMH. Knowledge transfer is supported by the
Extension of Community Healthcare Outcomes (ECHO)
Ontario Mental Health at CAMH and the University of
Toronto, which consists of specialist hubs connected with
multiple spoke (learner) teams in remote areas through
secure multipoint videoconferencing technology. ECHO
is designed to facilitate an interprofessional community
of practice, provide access to specialised expertise and
overcome geographic barriers in relation to coordinated
specialty care. It has evidence of clinical effectiveness
in the USA,30 and high provider satisfaction, increased
knowledge and self-efficacy in managing mental health
and addictions in rural and remote settings in Ontario.31
This implementation plan prioritises affordability,
Kozloff N, et al. BMJ Open 2020;10:e034280. doi:10.1136/bmjopen-2019-034280
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adaptability, spread and sustainability, as well as patient
and caregiver engagement. In addition to collecting
individual-level data, the study will examine outcomes
with relevant comparison groups in administrative data
held at Institute for Clinical Evaluative Sciences (ICES)
at dramatically lower time and cost compared with an
RCT.
Objectives
Early Psychosis Intervention-
Spreading Evidence-
based
Treatment (EPI-
SET), a multisite non-
randomised
effectiveness-implementation hybrid type III trial,32 will
evaluate the implementation and impact of NAVIGATE
in five EPI programmes in Ontario, supported by PSSP’s
provincial regional network of implementation experts,
and training through ECHO. First, we will assess at a
programme level whether implementation of NAVIGATE, as a structured model of care, leads to improved
fidelity to the EPI standard. Because NAVIGATE has not
been evaluated in Ontario, which, unlike the original
RAISE Study setting in the USA, is characterised by established EPI programmes and a system of universal healthcare, we will also assess the effectiveness of NAVIGATE
in improving individual-level outcomes over time, and
system-level outcomes using quasi-experimental methods
and administrative data. Lastly, we will measure youth and
family member engagement in the study. Specifically, our
primary objectives are to:
►► Assess implementation of NAVIGATE and whether
this leads to improvement in fidelity to the EPI standards (using the FEPS-FS).26
►► Determine longitudinal change in functioning and
symptoms in NAVIGATE patients.
►► Compare system-
level outcomes, including days in
hospital, ED visits, suicide attempts, mortality and
system costs among patients receiving NAVIGATE
compared with patients at other EPI sites not receiving
NAVIGATE as well as patients with psychotic disorders
who are not enrolled in EPI.
►► Evaluate youth and family member engagement in
this implementation study according to established
frameworks.
Methods and analysis
Study setting
Ontario is the most populous province in Canada, with
a population of approximately 14 million and a system
of universal healthcare delivered through the Ontario
Health Insurance Plan (OHIP). Five EPI programmes
have been selected to represent different geographic
regions of Ontario. Each site offers services from a psychiatrist as well as other health professionals (nurses, occupational therapists and social workers) who provide case
management and family support. The diversity of sites
allows for the opportunity to examine subpopulations,
including ethno-
racial minority groups, Indigenous
populations and rural residents. CAMH acts as the coordinating site.
Kozloff N, et al. BMJ Open 2020;10:e034280. doi:10.1136/bmjopen-2019-034280

Eligibility criteria
Mirroring the RAISE Study, we will recruit 400 patients
(100 in months 6–12, 300 in months 12–24) into the study
with a 2-year follow-up.33 Participants will be in their first
year of treatment in the participating EPI programmes.
Inclusion criteria are broad, reflecting the real-
world
populations served by the programmes.
Inclusion criteria
Age range of 14–35 years.
Any Diagnostic and Statistical Manual of Mental
Disorders (DSM-5) diagnosis that can manifest as
FEP (schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar I disorder with psychotic
features, major depressive disorder with psychotic
features, substance-
induced psychotic disorder or
unspecified psychotic disorder).
►► Within first year of treatment at a participating EPI
programme.
►►
►►

Exclusion criteria
Absence of psychosis.
Inability to provide informed consent to participate in
the research study.

►►
►►

Objective 1: implementation and evaluation
Implementation plan
Participating EPI programmes are guided through a
facilitated, staged, change process.34 35 Regional PSSP
facilitators lead implementation in collaboration with
NAVIGATE trainers, CAMH NAVIGATE experts and
the EPI programme staff lead at each site.36 ECHO will
become increasingly involved over time to support NAVIGATE as part of routine practice, and this will also be
monitored. The stages of our implementation process are
summarised in table 1.
Implementation evaluation
The implementation evaluation is summarised in table 2.37
Fidelity to the EPI standard, our primary outcome, will
be assessed using the FEPS-FS.26 The FEPS-FS is a validated measure of fidelity of service delivery to the current
standard of EPI evidence-
based practice based on 32
program-specific items (individual and team practices)
rated on a 5-point scale from ‘not implemented’ to ‘fully
implemented’. A rating of 4 is considered satisfactory
adherence. Trained assessors will review site administrative data, data abstracted from client health records
and conduct phone interviews with site staff to complete
the FEPS-FS. Fidelity assessments will be conducted for
each site at baseline, 1 year and 2 years post implementation. Descriptive statistics (percentages, means and
ranges) will be reported for the total scale score and for
subscale scores that align with NAVIGATE components.
With a small number of sites, we cannot quantitatively test
changes over time and across sites but will describe and
qualitatively compare findings.
To determine whether implementation of NAVIGATE
is associated with improvement in fidelity to the EPI
3
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Table 1 Stages of implementation to be used in EPI-SET
Stage

Overarching goal

Steps

1. Exploration

To assess site capacity and ►► CAMH NAVIGATE experts, PSSP implementation specialists and ECHO team meet with
need, build engagement
each site to explain NAVIGATE, learn about their current staffing and service delivery
processes and discuss how to integrate NAVIGATE into their practice.
►► EPI staff complete a site readiness assessment survey and a programme fidelity review is
conducted to learn more about site capacities and needs for NAVIGATE implementation.

2. Installation

To create structures
and build capacity for
implementation

►► EPI staff and PSSP facilitators meet for an intensive in-person and/or blended in-person
and virtual staff training over several days co-led by CAMH NAVIGATE experts and
NAVIGATE trainers along with youth and family partners, delivered in lectures, role playing
and discussions.
►► PSSP supports preparation, including staff allocation to each NAVIGATE role, how
interventions will be documented, how documentation will be used in NAVIGATE
supervision and how to prepare for ECHO sessions.
►► The ECHO team works with each site to ensure setup and ongoing functioning of
infrastructure for live videoconferencing.

3. Initial
implementation

To trial and refine
implementation

►► Each site will begin NAVIGATE delivery using feedback from various sources, including
ECHO training and coaching, contact and progress notes, and staff meetings to refine the
implementation and service delivery processes and to build staff skills.
►► The PSSP implementation specialists will document progress, strategies and challenges
to implementation in a structured log that they will share in regular meetings with the
NAVIGATE experts and other facilitators for continuous improvement, mindful of site-
specific factors and population-specific factors (eg, sex, race/ethnicity, rural vs urban) that
may influence implementation.
►► Staff feedback will be used to refine the implementation process.

4. Full
implementation
and sustainability

To stabilise practice so that ►► NAVIGATE is fully embedded into the organisation and can be sustained with internal
the implemented practice
resources.
►► The ECHO team will work in collaboration with Study sites via videoconferencing
is routine
technology to create and sustain a community of practice for NAVIGATE implementation
and spread beyond the duration of this study, such that it becomes routine practice.
►► After each ECHO session, questionnaires will be used to evaluate satisfaction and
inform ECHO modifications, and cases discussed during the sessions will generate
implementation recommendations, with surveys approximately 3 months later to evaluate
adherence to these recommendations.
►► Pre-knowledge and post-knowledge tests and competence assessments will be used to
assess how knowledge changes throughout the ECHO cycle.

CAMH, Centre for Addiction and Mental Health; ECHO, Extension of Community Healthcare Outcomes; EPI, early psychosis intervention; EPION,
Early Psychosis Intervention Ontario Network; EPI-SET, Early Psychosis Intervention-Spreading Evidence-based Treatment; PSSP, Provincial System
Support Program.

standard, programme staff will document delivery of core
modules for each of the four interventions. We will calculate the percentage of core modules completed per intervention per patient to assess penetration and to identify
variations in delivery both within sites and across sites.
Additionally, we will calculate frequency of team activities
(eg, weekly meetings, direct supervision) and assess staff
perceived competence in delivery of NAVIGATE using
the readiness monitoring tool38 and the competency
assessment questionnaires completed at the conclusion
of each ECHO cycle (see below).
The consolidated framework for implementation
research (CFIR)39 40 will be used to systematically assess
contextual factors that are associated with effective implementation in relation to five major domains: intervention characteristics (eg, complexity, relative advantage),
outer setting (eg, external policy, patient needs), inner
setting (eg, resources, fit, leadership), staff characteristics (eg, knowledge, beliefs) and implementation process
(eg, facilitation, planning, coaching). A semi-structured
interview will guide data collection.39 41 Interviews will
be conducted with EPI staff and organisation leaders at
4

each site at the end of the active implementation and
will be recorded and transcribed. The CFIR will provide
the organising framework for qualitative data coding and
analysis. At each analysis stage, coding and development
of emergent themes will be conducted by multiple coders
using NVivo software, with consensus achieved through
discussion and deliberation. In combination with fidelity
results, we will examine implementation facilitators and
challenges within and across sites.
Following an established evaluation framework developed by ECHO that builds on continuing education
programme evaluation,42–44 we will assess staff participation and retention, satisfaction with ECHO support
and perceived changes in competence to deliver NAVIGATE. Competency assessment questionnaires will be
administered to staff prior to participation in ECHO
sessions and at the conclusion of each ECHO cycle to
assess changes in attitudes, knowledge and self-efficacy
(self-
reported competence) in delivering NAVIGATE
components.31
Kozloff N, et al. BMJ Open 2020;10:e034280. doi:10.1136/bmjopen-2019-034280
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Table 2 Implementation evaluation measures and timeline
Implementation stage

Explore (stage 1)

Install (stage 2)

Initial
implementation
(stage 3)

Capacity
and needs
assessment

Plan and
prepare

Trial and refine

Stabilise
practice

Practice is
routine

Months
1–3

Months
4–6

Months
7–12

Months
13–24

Months 25–42

 Implementation
Tracker tool based on
milestones, risk, action NIRN framework90

•

•

•

•

•

 ECHO implementation
(clinical coaching)

•

•

•

•

•

•

•

•

•

•

•

Measurement domain

Measure

Full implementation and
sustainability
(stage 4)

Implementation process

Post-session
questionnaires and
phone calls

Implementation outcomes (organisational capacity)
 Readiness to
implement

RMT adapted38

•

 Fidelity to EPI model

FEPS-FS26

•

 Fidelity to NAVIGATE

Module checklist

 Staff perceptions of
value and feasibility*

•

39 40

•

•

CFIR adapted

 Implementation outcomes (staff capacity)
 Staff knowledge and
skills

ECHO survey

•

•

•

*Includes perceptions of ECHO support.
CFIR, consolidated framework for implementation research; ECHO, Extension of Community Health Outcomes; EPI, early psychosis intervention;
FEPS-FS, First Episode Psychosis Services–Fidelity Scale; NIRN, National Implementation Research Network; RMT, readiness monitoring tool.

Objective 2: evaluation of individual-level outcomes
Study procedures
Participant recruitment will be initiated by the clinical team
at each participating site who will obtain verbal permission
from potential participants to be contacted by a member of
the research team. The research team will then meet with
participants via live two-
way videoconference, consistent
with ECHO infrastructure, to obtain informed consent.
Participants will read the consent form online and have
the opportunity to ask the research team questions in real
time over videoconference. Participants will provide digital
consent signatures by clicking a checkbox to indicate their
consent. A copy of the signed consent will be emailed (or
mailed, if requested) to the participant. A family member of
each patient will also be invited to participate in the study.
All interviewer-rated assessments will also be administered
via two-way live videoconference by trained interviewers,
in a manner identical to the approach used in the original
RAISE Trial.21 This method of remote assessment is comparable to in-
person assessments for both patient acceptability and reliability.45 De-identified study data, including
interviewer-
rated and participant/family member self-
report assessments, will be entered and managed using
research electronic data capture tools hosted at CAMH.46 47
It is anticipated that the first participant will complete the
study in month 30, while the final participant will complete
a 2-year follow-up at month 48.
Kozloff N, et al. BMJ Open 2020;10:e034280. doi:10.1136/bmjopen-2019-034280

Outcome measures
Individual-level outcome measures are outlined in table 3.
Participants will be administered the Structured Clinical
Interview for DSM-5 for formal diagnostic assessment,48
with information supplemented by the clinical team as
needed. Demographics and a medical history will also be
recorded at baseline.
Functioning will be assessed with the Heinrichs-Carpenter
Quality of Life Scale (QLS), administered by semi-
structured interview.49 The QLS is the most comprehensive
measure of community functioning in schizophrenia populations50 and the primary outcome in the RAISE Trial.21
While the QLS is psychosis-specific, we will measure general
functioning using the 12-item self-report WHO Disability
Assessment Schedule 2.0 (WHODAS 2.0),51 consistent with
DSM-5 recommendations for use across mental illnesses.48
The interviewer-rated Brief Psychiatric Rating Scale 24-item
will be used to assess symptom severity52 and the Clinical
Global Impression Scale will characterise overall illness
severity and improvement.53Depression symptoms and
severity will be assessed with the Patient Health Questionnaire-9 (PHQ-9).54 The Adolescent Alcohol and Drug
Involvement Scale (AADIS) will be administered to characterise current substance use.55 The Service Use and
Resource Form will be used to measure utilisation of mental
health and other medical services across residential, inpatient and outpatient treatment settings, with an add-on item
5

BMJ Open: first published as 10.1136/bmjopen-2019-034280 on 3 June 2020. Downloaded from http://bmjopen.bmj.com/ on April 25, 2022 at UNM Health Sciences Library and Informatics
Center. Protected by copyright.

Open access

Table 3 Participant and family member assessment tools and schedule*
Months from baseline
Assessments

Construct

Who completes

0

6

12

18

24

Youth

•

Psychopathology

Interviewer

•

Youth

•

Condition-specific quality of life

Interviewer

•

•

•

•

•

Generic quality of life

Youth

•

•

•

•

•

Screening
 Demographic form
 SCID-548 (all modules)
 Medical history
Functional assessments
 QLS49
 WHODAS 2.0
version)

51

(self-administered

Clinical assessments
Psychopathology
 SCID-548 (mood disorder, psychotic
disorder, substance use disorder, anxiety
disorder and obsessive-compulsive and
related disorder modules)

Interviewer

 BPRS52

Psychotic symptoms

Interviewer

•

•

•

•

•

 CGI53

Overall illness severity and
improvement

Interviewer

•

•

•

•

•

 PHQ-954

Depression

Youth

•

•

•

•

•

 AADIS55

Substance use

Youth

•

•

•

•

•

Service utilisation

Youth

•

•

•

•

•

Satisfaction with services

Youth

•

•

•

•

•

Therapeutic relationship

Youth

•

•

•

•

•

Perceptions of recovery principles
and overall quality of services

Youth

•

•

•

•

•

 WHODAS 2.051 (proxy-administered
version)

Generic quality of life

Family member

•

•

•

•

•

 LSP-2061–63

General functioning

Family member

•

•

•

•

•

Satisfaction with services

Family member

•

•

•

•

•

Caregiver quality of life

Family member

•

•

•

•

•

•

•

Service utilisation
 SURF56
Satisfaction, care quality and therapeutic
relationship
 OPOC-MHA58 (client version)
 STAR-P

59

 RSA60
Family member-completed assessments

 OPOC-MHA
 S-CGQoL64

58

(caregiver version)

*Time indicates months after NAVIGATE initiation for each participant.
.AADIS, Adolescent Alcohol and Drug Involvement Scale; BPRS, Brief Psychiatric Rating Scale; CGI, Clinical Global Impression; LSP-20, Life Skills
Profile-20; OPOC-MHA, Client Ontario Perception of Care Tool For Mental Health and Addictions; PHQ-9, Patient Health Questionnaire-9; QLS,
Quality of Life Scale; RSA, Recovery Self-Assessment; S-CGQoL, Schizophrenia Caregiver Quality of Life Questionnaire; SCID-5, Structured Clinical
Interview for DSM-5; STAR-P, Scale to Assess Therapeutic Relationships—Patient Version; SURF, Service Use and Resource Form; WHODAS 2.0,
WHO Disability Assessment Schedule 2.0.

to assess medication adherence.56 Most of the patient-level
assessment tools selected were those used in the original
RAISE Study, with the exception of the PHQ-9 for depression (vs the Calgary Depression Scale for Schizophrenia,57
since Ontario EPI programmes treat affective as well as
non-affective psychosis), and the addition of the AADIS.
To measure satisfaction with their care, participants will
complete the Client Ontario Perception of Care Tool For
Mental Health and Addictions (OPOC-MHA).58 The Scale
to Assess Therapeutic Relationships—Patient Version will
be used to assess participants’ perception of the therapeutic
relationship with their care team,59 and perspectives on the
6

quality of care will be assessed using the participant-rated
Recovery Self-Assessment Scale.60
To capture the caregiver’s perspective on the participant’s
functioning, a family member will complete the 12-item
proxy-administered version of the WHODAS 2.0, as well
as the Life Skills Profile-20.61–63 Family members will also
complete the caregiver version of the OPOC-MHA to assess
their satisfaction with care and the Schizophrenia Caregiver
Quality of Life Questionnaire64 to assess their quality of life.
Statistical analysis
First, we will undertake a pre-post analysis of all of the
clinical outcome variables. Next, we will compare clinical
Kozloff N, et al. BMJ Open 2020;10:e034280. doi:10.1136/bmjopen-2019-034280
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outcomes common to both EPI-SET and the RAISE Trial
with the aggregate data from the RAISE Study to assess
comparability of the intervention in different jurisdictions,
using a matching-adjusted indirect comparison model.65
In this approach, we adjust the population receiving the
intervention to match the average baseline characteristics with a reference population using propensity scores.
We then compare outcomes across balanced populations.
This is facilitated by the use of individual patient data (ie,
individual-level outcome measures as in the RAISE Study)
and the collection of similar baseline characteristics that
might influence outcome (eg, age, education, sex, baseline illness severity, duration of untreated psychosis). As
with RAISE, the primary outcome of this subproject will
be the total QLS Score. We will compare our sample with
the matched RAISE sample on mean or median changes in
patient-level outcome data. We will also identify subgroups
of patients with different functional outcome and symptom
trajectories using latent class growth analysis and latent
growth mixture modelling.
Overall retention rate at each data point is expected to
fall within the acceptable range for statistical correction.
Every effort will be made to prevent dropouts/missing data
and to complete relevant assessments for participants who
drop out, including reasons for dropout. As is typical in
longitudinal research, we anticipate non-random missing
data. Sensitivity analysis will be conducted to evaluate the
impact of non-random missing data. We will use a variety
of software platforms to perform the described analyses
including the Mplus platform (Muthen and Muthen, 2009–
2016) and the R Project for Statistical Computing. As we
anticipate missing data both within and across assessments,
both cross-sectional and longitudinal missing data will be
handled using best practice procedures including multiple
imputation and full-information likelihood estimation.
Objective 3: evaluation of system-level outcomes
Data sources
The primary data collected for patients receiving NAVIGATE in the study sites will be linked deterministically to
data sources held at ICES via unique OHIP number. Only
NAVIGATE patients who have consented will have their
program-level data linked to ICES data. The following ICES
data sources will be used: the Registered Persons Database,
which contains information on patient demographics and
deaths; the OHIP database, which captures data for physician visits and respective billings66; the Canadian Institute
for Health Information Discharge Abstract Database, which
captures all non-
psychiatric and non-
adult psychiatric
hospitalisations66 67; the Ontario Mental Health Reporting
System, which captures adult psychiatric hospitalisations68;
the National Ambulatory Care Reporting System, which
captures ED visits and other ambulatory care69 and the
Ontario Drug Benefits (ODB) claims data, which provides
information on all outpatient prescriptions covered by ODB
(based on financial need for those under 65 years of age and
for young people up to age 25 who lack private insurance).
Kozloff N, et al. BMJ Open 2020;10:e034280. doi:10.1136/bmjopen-2019-034280

These databases can be linked via the encrypted health
card number such that all the information is available for
each individual, and de-identified. The health administrative data used for this analysis are collected by the Ministry
of Health and stored by ICES without patient consent with
a number of protections in place that have been described
elsewhere (www.ices.on.ca). Data will be stored and analysed onsite at ICES following procedures approved by
Ontario’s Information and Privacy Commissioner.
Study design
This universal administrative data source allows us to
compare outcomes among study participants and two
comparison groups: (1) FEP patients in Ontario who have
received EPI services at non-NAVIGATE sites and (2) FEP
patients who have not received EPI services. Comparison
groups will be identified using a validated algorithm that
detects incident cases of psychotic disorders in the administrative data.70 We will use propensity score methods to
ensure comparison populations are similar to NAVIGATE
participants based on observed characteristics.71 A propensity score is defined as the probability that a person is in
the ‘exposed’ category. In this case, the exposure condition
is access to the NAVIGATE protocol. The propensity score
is developed using logistic regression to model exposure
to NAVIGATE as a function of observed covariates likely
to affect the probability of receiving the intervention to
yield a probability of NAVIGATE access for each subject,
and therefore creates a scenario whereby individuals who
do and do not receive NAVIGATE are comparable based
on measurable variables within the propensity score model.
The propensity score model will include sociodemographic
characteristics, clinical factors and prior service use. Individuals who used EPI services within 5 years preceding the
index date will be excluded.
Outcomes
Our primary outcome is number of psychiatric hospitalisation days in the year following the index date (NAVIGATE baseline). Secondary outcomes will include ED visits,
suicide attempts, mortality, number of psychiatric hospitalisations, time to first psychiatric hospitalisation, visits to
outpatient psychiatrists and visits to outpatient primary care
providers, stratified as mental health versus non-
mental
health-related.72–74
Covariates
We will extract information on sociodemographic characteristics, including age, sex, neighbourhood-level income
quintile and rurality of residence. Clinical covariates will
include type of diagnosis (schizophrenia, mood disorder
and so on), source of index diagnosis (hospitalisation,
outpatient visit) and history of visits with alcohol-related
or substance-related diagnoses. We will also measure prior
service use for mental disorders, including the number
of mental health-related visits to primary care providers,
psychiatrist visits, mental health-related ED visits and psychiatric hospitalisations.
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Statistical analysis
Our primary outcome for Objective 3 is number of psychiatric hospitalisation days in the year following NAVIGATE
admission. We will compare the three groups (NAVIGATE,
non-NAVIGATE EPI users and non-EPI users with FEP)
across all covariates listed above. We will subsequently
model total mental health-related hospital days. The regression model will be determined by the distribution of the
dependent variables. If normally distributed, we will use
linear regression; if the distribution assumes a Poisson
distribution, we will use Poisson regression. Secondary
outcomes will be modelled using logistic regression (for
binary outcomes) or Cox proportional hazard modelling
(for time-to-event outcomes).
Cost analysis
We will employ a costing algorithm available at ICES75 to
estimate all direct patient-level healthcare costs incurred by
the public third-party payer (Ontario Ministry of Health)
across the three comparison groups. This will include costs
of hospitalisations (both non-psychiatric and psychiatric);
ED visits; physician services (ie, primary care, psychiatry and
other) and diagnostic tests; outpatient prescription drugs
for individuals covered under the ODB programme; home
care; long-term care and other care. Further details on
the methodology to calculate cost for each type of healthcare service can be found elsewhere.76 Costs will then be
compared between groups to ascertain whether there are
any cost savings associated with NAVIGATE. Furthermore,
assuming that all subjects will incur healthcare costs, we will
use a generalised linear model with a gamma distribution
and a log link to model healthcare costs and determine the
main cost drivers. Actual model parameters will be determined by the nature of the cost distributions.
Objective 4: evaluation of engagement of people with
lived experience
Consistent with best practices for youth77–79 and patient80–85
engagement, opportunities for youth and family participation will range from ad hoc, limited commitment (eg,
surveys or interviews) to full, ongoing participation with
opportunities for research team membership and mentorship. A youth and family member who previously received
EPI services at CAMH have collaborated on the project from
its inception. When the study launched, youth and family
advisory committees were formally established, comprising
youth and family members (partners) from each study site.
These committees meet monthly (via ECHO-style videoconference or in-person) to guide the research team on
recruitment strategies, assessment and treatment protocols, outcome measures, interpretation of findings and
dissemination of the trial learnings to knowledge users.
A central research coordinator facilitates the meetings.
Each committee assigns a lead who is also a member of the
Central Steering Committee where decisions are made,
and represents the views of their members. Partners are
oriented to the study, their readiness to join the study team
8

is explored, and they receive NAVIGATE training tailored
to their learning needs. Scientific, clinical and programme
leaders receive training on how to include patients and
family members on a team in a meaningful manner. Partners are compensated for their involvement in this study.
Evaluation of youth and family engagement
In collaboration with the Patient Engagement Resource
Centre,86 we selected the Public and Patient Engagement
Evaluation Tool87 participant questionnaire for formative
and summative evaluation of the strength of the partner
engagement, and the PCORI engagement activity inventory (PECI)88 to capture partners’ contribution to the
EPI-SET Study. The tools are adapted based on partners’
feedback. At baseline, we assess the partners’ intent to
contribute to the various aspects of the research, and will
compare this to their reported contribution using the PECI
at three different times throughout the study. The baseline
questionnaire also assesses the partners’ and research team
members’ need for support to achieve authentic engagement, and resources are offered accordingly. Partners’
engagement experience with the advisory committee and
within the Central Steering Committee meetings is assessed
monthly for formative purposes, and used to correct
process as required to optimise experience. A summative
evaluation is conducted at the study end or when a member
leaves the committee.

Patient and public involvement
Patient involvement of youth and families with lived experience was informed by current best practices in the research
literature.77–85 A youth and family member who previously
received EPI services collaborated on the project from its
inception, with active participation on the project Steering
Committee where high-level decisions about the project are
made. They also lead the Youth Advisory Committee and
Family Advisory Committee, respectively. These committees include patients who have received care from the local
study sites. In monthly meetings in-person and by videoconference as well as over email, the youth and family members
draw on their past experiences to help guide project decisions. Individual-
level assessments completed by youth
have all been reviewed and selected by the Youth Advisory
Committee and assessments completed by caregivers by the
Family Advisory Committee. Study principal investigators
representing the different project objectives rotate through
attending the Youth Advisory Committee and Family
Advisory Committee meetings as another mechanism for
regular bidirectional communication.
The perspectives of enrolled study participants are
privileged through the many self-report assessments they
are asked to complete including measures of their experiences receiving NAVIGATE. Study participants who
indicate their interest in receiving published materials
presenting results of the study will provide their email
address and will be contacted as materials are published.
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For additional details on patient and public involvement,
please see Objective 4.
Ethics and dissemination
The study was approved by the Research Ethics Board
(REB) at Lakeridge Health, Niagara Region Public Health,
North Bay Regional Health Centre, Health Sciences North
and the Canadian Mental Health Association Waterloo
Wellington, in addition to the coordinating centre, the
Centre for Addiction and Mental Health. The study
protocol was prepared according to SPIRIT guidelines
approved protocol
(online supplementary file l).89 REB-
amendments will be posted on c linicaltrials.gov. The principal investigators, scientific committee and study team will
meet regularly to review accrued data, data confidentiality,
adherence to protocol design, recruitment and implementation. During meetings, the scientific committee will also
review the enrollment of data, the accrual and integrity of
clinical data, implementation and fidelity of NAVIGATE
and any adverse event associated with the various components of the study.
The results of each of the four study objectives will be
reported in scientific journal articles and shared with key
stakeholders as they become available. The study has been
discussed at regular EPION meetings (of programme
managers and other representatives) and will be formally
presented at its bi-annual conference. De-identified participant data are available on reasonable request for each
objective except system-level data held at ICES. A publications committee will manage access to data. Requests can
be made by contacting principal investigator Dr. Aristotle
Voineskos at aristotle.voineskos@camh.ca.
Conclusions
This multisite non-
randomised pragmatic hybrid
effectiveness-
implementation type III mixed methods
study leverages collaboration with multiple stakeholders
to evaluate implementation of NAVIGATE in diverse EPI
programmes in Ontario. It is expected that implementation will lead to improved fidelity to the EPI model, a
community of practice and model for continuous learning
for EPI programmes in Ontario, and improvements in
patient symptoms, functioning and service utilisation (ie,
diversion from acute mental health treatment including
hospitalisation days), with meaningful engagement of
youth and family members in the research process. It is
anticipated that this research will highlight key ingredients for spread and scale of the NAVIGATE model to
additional settings with the goal of improving recovery
for YEAs with psychosis.
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